Saundra Flynn
About Saundra Flynn
Saundra Flynn is currently the Associate Brand Manager Interim at Bristol Myers Squibb in the United Kingdom, with over 20 years of professional experience in finance and the pharmaceutical industry.
Title
Saundra Flynn is currently serving as the Associate Brand Manager Interim at Bristol Myers Squibb in the United Kingdom.
Company
Saundra Flynn is currently employed by Bristol Myers Squibb, a global biopharmaceutical company, where she holds the position of Associate Brand Manager Interim.
Professional Experience at Celgene
Saundra Flynn worked at Celgene for three years, where she first held the position of Key Account Manager from 2018 to 2019 and then advanced to the role of Senior Key Account Manager from 2019 to 2021.
Role at Boston Scientific
At Boston Scientific, Saundra Flynn served as the National Territory Manager from 2014 to 2018. During this period, she was responsible for managing territories on a national level.
Career at Teva Pharmaceuticals
Saundra Flynn worked at Teva Pharmaceuticals for nine years, from 2005 to 2014. She held the position of District Healthcare Specialist during her tenure at the company.
Finance Roles
Saundra Flynn has a strong background in finance, having worked in several hedge fund accounting roles in Dublin. She was a Senior Hedge Fund Accountant at J.P. Morgan for one year and an Assistant Manager for Hedge Fund Accounting at PFPC for three years.
Educational Background
Saundra Flynn has a diverse educational background. She earned a Bachelor of Commerce (B.Com.) degree from University College Cork and a Certificate in Mutual Funds from The Institute of Banking. Further, she holds diplomas and certificates in pharmacology and the promotion of prescription medicines from the Medical Representative Institute of Ireland and The Association of the British Pharmaceutical Industry.
Transition from Finance to Pharmaceuticals
Saundra Flynn made a notable career shift from finance to the pharmaceutical industry. After starting her career with roles such as Junior Fund Accountant at Baring Asset Management and Senior Hedge Fund Accountant at J.P. Morgan, she transitioned into pharmaceutical roles at companies like Teva Pharmaceuticals and Celgene.